Keywords
How to Cite
Abstract
Purpose: To study short-term outcomes of thermochemoradiotherapy (TCRT) followed by radical surgery in patients with non-small cell lung cancer (NSCLC). Materials and methods: The study included 38 patients with stage III lung cancer, who were treated at the Cancer Research Institute of the TNIMC (Tomsk, Russia). The study group patients (n=18) received combined modality treatment consisting of hyperfractionated radiation therapy (40 Gy total dose in twice-daily fractions of 1.3 Gy each) given concurrently with 2 cycles of chemotherapy with paclitaxel / carboplatin after 10 sessions of local hyperthermia followed by surgery. In the control group (n = 20), only surgical treatment was performed. Results: The overall tumor response to TCRT was 94.4%, including complete response (22.2%) and partial response (72.2%). All patients tolerated local hyperthermia well. All patients (100%) underwent radical surgery. There were 23 (60.5%) lobectomies, 13 (34.2%) pneumonectomies and 2 (5.3%) combined surgeries. Postoperative complications were observed in 22.2% of patients in the study group and in 20.0% of patients in the control group. The mortality rates were 0 and 5.0%, respectively (р>0.05). Conclusion: Preoperative TCRT in patients with stage III NSCLC resulted in a significant tumor regression, was well tolerated by the patients and did not have a negative impact on postoperative period and mortality.
References
Белялова Н.С., Дворниченко В.В., Менг А.А., Моклоков А.В., Лелявин Б.И., Сокольников М.В., Улыбин П.С., Хаматов Р.К. Факторы риска хирургии легких: возраст и респираторная функция // Российский онкологический журнал. - 2009. - Т. 1. - С. 48-50.
Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). Под ред. А.д. Каприна, В.В. Старинского, Г.В. Петровой. - М.: МНИОИ им. П.А. Герцена - филиал ФГБУ "НМИЦ радиологии" Минздрава России, 2019. - 250 с.
Интраоперационная электронная и дистанционная гамма-терапия злокачественных новообразований / Под ред. чл.-корр. РАМН, проф. Е.Л. Чойнзонова и проф. Л.И. Мусабаевой. - Томск: НТЛ, 2006. - 215 с.
Albain K.S., Swann R.S., Rusch V.W. et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial // Lancet. - 2009. - Vol. 374(9687). - P. 379-386. - DOI: 10.1016/s0140-6736(09)60737-6
Chen F., Okubo K., Sonobe M. et al. Hyperfractionated Irradiation with 3 Cycles of Induction Chemotherapy in stage IIIA-N2 Lung Cancer // World J. Surg. - 2012. - Vol. 36(12). - P. 2858-2864. - DOI: 10.1007/s00268-012-1747-1
Daly B.D., Cerfolio R.J., Krasna M.J. Role of surgery following induction therapy for stage III non-small cell lung cancer // Surg Oncol Clin N Am. - 2011. - Vol. 20(4). - P. 721-732. - DOI: 10.1016/j.soc.2011.07.006
Ebara T., Sakurai H., Wakatsuki M. et al. Inoperable Pancoast tumors treated with hyperthermia-inclusive multimodality therapies // Lung Cancer. - 2009. - Vol. 63(2). - P. 247-250. - DOI: 10.1016/j.lung-can.2008.05.023
Fujita S., Katakami N., Takahashi Y. et al. Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer // Eur. J. Cardio-thorac. Surg. - 2006. - Vol. 29(6). - P. 896-901. - DOI: 10.1016/j.ejcts.2006.03.023
Kim A.W., Boffa D.J., Wang Z., Detterbeck F.C. An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer // -J. Thorac. Cardiovasc. Surg. - 2012. - Vol. 143(1). - P. 55-63. - DOI: 10.1016/j.jtcvs.2011.09.002
Koshy M., Fedewa S.A., Malik R. et al. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer // J. Thorac. Oncol. - 2013. - Vol. 8(7). - P. 915-22. - DOI: 10.1097/JTO.0b013e31828f68b4
Moon S.D., Ohguri T., Imada H. et al. Definitive radiotherapy plus regional hyperthermia with or without chemotherapy for superior sulcus tumors: a 20-year, single center experience // Lung Cancer. - 2011. - Vol. 71(3). - P. 338-343. - DOI: 10.1016/j.lung-can.2010.06.007
Mordant P., Fabre É., Gibault L. et al. Impact of induction therapies on pathology and outcome after surgical resection of non-small lung cancer: a 30-year experience of 859 patients // Rev Pneumol Clin. - 2014. - Vol. 70(1-2). - P. 9-15. - DOI: 10.1016/j.pneu-mo.2013.12.008
NsCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data // Lancet. - 2014. - Vol. 383(9928). - P. 15611571. - DOI: 10.1016/s0140-6736(13)62159-5
Sakao S., Takiguchi Y., Nemoto K. et al. Thermoradiotherapy for local control of chest wall invasion in patients with advanced non-small cell lung cancer // Int. J. Clin. Oncol. -2002. - Vol. 7(6). - P. 343-348. - DOI: 10.1007/s101470200052
Thomas P.A., Berbis J., Baste J.M. et al. Pneumonectomy for lung cancer: contemporary national early morbidity and mortality outcomes // -J. Thorac. Cardiovasc. Surg. 2015. - Vol. 149(1). - P. 73-82. - DOI: 10.1016/j.jtcvs.2014.09.063
Venuta F., Anile M., Diso D. et al. Operative complications and early mortality after induction therapy for lung cancer // Eur. J. Cardiothorac. Surg. - 2007. - Vol. 31(4). - P. 714-717. - DOI: 10.1016/j.ejcts.2007.01.017
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2020